Cargando…
The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation
Letrozole, an aromatase inhibitor, has been demonstrated to be effective as an ovulation induction and controlled ovarian hyperstimulation agent. However, dose administration has generally been limited to 5 days at 2.5 to 7.5 mg daily. We undertook a retrospective review of over 900 treatment cycles...
Autores principales: | Pritts, Elizabeth A., Yuen, Alexander K., Sharma, Shefaali, Genisot, Robert, Olive, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236406/ https://www.ncbi.nlm.nih.gov/pubmed/22191042 http://dx.doi.org/10.5402/2011/242864 |
Ejemplares similares
-
Current evidence supporting “letrozole” for ovulation induction
por: Kar, Sujata
Publicado: (2013) -
Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: An RCT
por: Farzaneh, Farahnaz, et al.
Publicado: (2020) -
Efficacy of letrozole versus clomiphene citrate on ovulation induction in patients with polycystic ovarian syndrome
por: Khakwani, Mehnaz, et al.
Publicado: (2022) -
Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023) -
A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome
por: Roy, Kallol Kumar, et al.
Publicado: (2012)